Clinical Trial Update: Retisert and Cataract Surgery in Patients With Severe Uveitis [NA]

View source ↗

Summary

A completed clinical trial update evaluating Retisert (fluocinolone acetonide intravitreal implant) in patients with severe uveitis undergoing cataract surgery.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermediate Uveitis
• Posterior Uveitis

Drugs mentioned

• Retisert (fluocinolone acetonide)

Snippet

Sponsor: Duke University | Conditions: Intermediate Uveitis, Posterior Uveitis | NA | Status: COMPLETED